Clinical Trials Directory

Trials / Completed

CompletedNCT02986763

Evaluation of Pesticide Exposure in the General Population

Evaluation of Pesticide Exposure in the General Population: Use of Spatial, Environmental, Toxicological and Biological Approaches

Status
Completed
Phase
Study type
Observational
Enrollment
166 (actual)
Sponsor
Centre Leon Berard · Academic / Other
Sex
Male
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

An association has been suggested with several diseases including cancer and IARC has classified several pesticides as carcinogenic, probably carcinogenic. There is a need for a better characterisation of environmental pesticides exposures and identification of suitable biomarkers of exposure and effect. A better understanding of the impact of pesticide exposure on metabolomic, transcriptomic and epigenetic changes, is essential to strengthen epidemiological hypotheses on the association with several cancer types. The main objective of the project is to validate a GIS (geographic information system) based method to assess environmental pesticide exposures, using environmental (contamination of housedust) and biological (blood and urine samples) measures. The project aims further to investigate a potential link between housedust contamination and biological measures in healthy non-smoking male residents and explore the impact of environmental pesticide exposure on metabolomics, transcriptomic and epigenetic parameters.

Detailed description

The project involves a pilot phase involving repeated (twice) sampling in 20 male non-smoking volunteers living in the Beaujolais region (France) to perform appropriate calibrations for metabolomic, transcriptomic and epigenetic analyses. The main study will be conducted in a sample of 150 male non-smoking volunteers and 50 professional pesticides applicators from the same region (3 sampling periods).

Conditions

Interventions

TypeNameDescription
BIOLOGICALQuestionnaire, blood, urine, hair and dust samplings

Timeline

Start date
2015-06-01
Primary completion
2017-03-01
Completion
2017-03-01
First posted
2016-12-08
Last updated
2018-02-09

Source: ClinicalTrials.gov record NCT02986763. Inclusion in this directory is not an endorsement.